Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

Similar articles for PubMed (Select 15637236)

1.

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.

Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, O'connell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK.

Science. 2005 Mar 4;307(5714):1434-40. Epub 2005 Jan 6.

2.

CCL3L1 and HIV/AIDS susceptibility.

Bhattacharya T, Stanton J, Kim EY, Kunstman KJ, Phair JP, Jacobson LP, Wolinsky SM.

Nat Med. 2009 Oct;15(10):1112-5. doi: 10.1038/nm1009-1112. No abstract available.

PMID:
19812561
3.

Susceptibility to HIV/AIDS: an individual characteristic we can measure?

Jülg B, Goebel FD.

Infection. 2005 Jun;33(3):160-2. Review.

PMID:
15940420
4.

HIV-1/AIDS susceptibility and copy number variation in CCL3L1, a gene encoding a natural ligand for HIV-1 co-receptor CCR5.

Nakajima T, Kaur G, Mehra N, Kimura A.

Cytogenet Genome Res. 2008;123(1-4):156-60. doi: 10.1159/000184703. Epub 2009 Mar 11. Review.

PMID:
19287150
5.

Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians.

Rathore A, Chatterjee A, Sivarama P, Yamamoto N, Singhal PK, Dhole TN.

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1149-56. doi: 10.1089/aid.2008.0019.

PMID:
19886839
6.

CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals.

Kulkarni H, Agan BK, Marconi VC, O'Connell RJ, Camargo JF, He W, Delmar J, Phelps KR, Crawford G, Clark RA, Dolan MJ, Ahuja SK.

PLoS One. 2008 Sep 8;3(9):e3165. doi: 10.1371/journal.pone.0003165.

7.

CCL3L1 and HIV/AIDS susceptibility.

Urban TJ, Weintrob AC, Fellay J, Colombo S, Shianna KV, Gumbs C, Rotger M, Pelak K, Dang KK, Detels R, Martinson JJ, O'Brien SJ, Letvin NL, McMichael AJ, Haynes BF, Carrington M, Telenti A, Michael NL, Goldstein DB.

Nat Med. 2009 Oct;15(10):1110-2. doi: 10.1038/nm1009-1110. No abstract available.

8.

CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.

Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, Anaya JM, Miura T, Hecht FM, Mamtani M, Pereyra F, Marconi V, Mangano A, Sen L, Bologna R, Clark RA, Anderson SA, Delmar J, O'Connell RJ, Lloyd A, Martin J, Ahuja SS, Agan BK, Walker BD, Deeks SG, Ahuja SK.

Nat Immunol. 2007 Dec;8(12):1324-36. Epub 2007 Oct 21.

PMID:
17952079
9.

CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection.

Shao W, Tang J, Song W, Wang C, Li Y, Wilson CM, Kaslow RA.

Genes Immun. 2007 Apr;8(3):224-31. Epub 2007 Mar 1.

PMID:
17330138
10.

CCL3L1 dose and HIV-1 susceptibility.

Mackay CR.

Trends Mol Med. 2005 May;11(5):203-6. Review.

PMID:
15882607
11.

Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis.

McKinney C, Merriman ME, Chapman PT, Gow PJ, Harrison AA, Highton J, Jones PB, McLean L, O'Donnell JL, Pokorny V, Spellerberg M, Stamp LK, Willis J, Steer S, Merriman TR.

Ann Rheum Dis. 2008 Mar;67(3):409-13. Epub 2007 Jun 29.

PMID:
17604289
12.

HIV/AIDS. HIV: experiencing the pressures of modern life.

Nolan D, James I, Mallal S.

Science. 2005 Mar 4;307(5714):1422-4. No abstract available.

PMID:
15746416
13.

[Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].

Wasik TJ, Smoleń J, Kruszyński P, Bratosiewicz-Wasik J, Beniowski M.

Wiad Lek. 2005;58(9-10):500-7. Polish.

PMID:
16529059
14.

Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia.

Nakajima T, Ohtani H, Naruse T, Shibata H, Mimaya JI, Terunuma H, Kimura A.

Immunogenetics. 2007 Oct;59(10):793-8. Epub 2007 Sep 14.

PMID:
17874089
15.

Reply to: "Experimental aspects of copy number variant assays at CCL3L1".

He W, Kulkarni H, Castiblanco J, Shimizu C, Aluyen U, Maldonado R, Carrillo A, Griffin M, Lipsitt A, Beachy L, Shostakovich-Koretskaya L, Mangano A, Sen L, Nibbs RJ, Tiemessen CT, Bolivar H, Bamshad MJ, Clark RA, Burns JC, Dolan MJ, Ahuja SK.

Nat Med. 2009 Oct;15(10):1117-20. doi: 10.1038/nm1009-1117. No abstract available.

PMID:
19812563
16.

Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C.

Grünhage F, Nattermann J, Gressner OA, Wasmuth HE, Hellerbrand C, Sauerbruch T, Spengler U, Lammert F.

J Hepatol. 2010 Feb;52(2):153-9. doi: 10.1016/j.jhep.2009.11.001. Epub 2009 Nov 27.

PMID:
20044164
17.

CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus.

Mamtani M, Rovin B, Brey R, Camargo JF, Kulkarni H, Herrera M, Correa P, Holliday S, Anaya JM, Ahuja SK.

Ann Rheum Dis. 2008 Aug;67(8):1076-83. Epub 2007 Oct 30.

18.

Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication.

Pilotti E, Elviri L, Vicenzi E, Bertazzoni U, Re MC, Allibardi S, Poli G, Casoli C.

Blood. 2007 Mar 1;109(5):1850-6. Epub 2006 Oct 24.

19.

Experimental aspects of copy number variant assays at CCL3L1.

Field SF, Howson JM, Maier LM, Walker S, Walker NM, Smyth DJ, Armour JA, Clayton DG, Todd JA.

Nat Med. 2009 Oct;15(10):1115-7. doi: 10.1038/nm1009-1115. No abstract available.

20.

The impact of CCL3L1 copy number in an HIV-1-infected white population.

Lee EY, Yue FY, Jones RB, Lo C, Sheth P, Hyrcza MD, Kovacs C, Benko E, Kaul R, Ostrowski M.

AIDS. 2010 Jun 19;24(10):1589-91. doi: 10.1097/QAD.0b013e3283398294.

PMID:
20442635
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk